Molecules 2012, 17(9), 10267-10275; doi:10.3390/molecules170910267
Article

Evaluation of in Vivo Antioxidant and Immunity Enhancing Activities of Sodium Aescinate Injection Liquid

1 Department of Hepatobiliary & Pancreatic Diseases, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai 200120, China 2 Department of General Surgery, Pudong New Area Zhoupu Hospital, Shanghai 201318, China These authors contributed equally to this work.
* Authors to whom correspondence should be addressed.
Received: 29 June 2012; in revised form: 13 August 2012 / Accepted: 14 August 2012 / Published: 27 August 2012
PDF Full-text Download PDF Full-Text [183 KB, uploaded 27 August 2012 16:52 CEST]
Abstract: Oxidative stress is involved in the development and progression of disease. Because sodium aescinate has been reported to have immunity enhancing and antioxidative effects, we investigated its activity by employing a hepatocellular carcinoma (HCC) mouse model. Sixty BALB/c mice were randomly divided into four groups, including a 1.4 mg/kg treated group (n = 15), a 2.8 mg/kg treated group (n = 15), an untreated hepatocellular carcinoma control group (n = 15) and a normal control group (n = 15). After H22 cells were cultured for one week, we collected 2 × 106 cells and injected them subcutaneously as 0.2 mL cell suspensions in sterile saline into the right shoulder region of every mouse. The animals were monitored for changes in activity, physical condition and body weight during the experiment. The next day after injection of H22 cells, animals in these test groups received one intraperitoneal injection of drug or physiological saline for 13 days. Results showed that in the sodium aescinate injection liquid (SAIL)-treated HCC mice, serum interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), Gamma-glutamyltransferase (γ-GT), alanine transaminase (ALT), aspartate transaminase (AST) and alkaline phosphatase (ALP) levels were significantly decreased compared with normal control mice. In addition, treatment with sodium aescinate injection liquid significantly decreased blood and liver malondialdehyde (MDA) levels, increased glutathione (GSH) levels, and antioxidant enzyme [superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px)] activities in a dose-dependent manner. We conclude that sodium aescinate injection liquid can decrease oxidative injury and enhance immunity functions in HCC mice.
Keywords: sodium aescinate; antioxidant; immunity; IL-1β; SOD; CAT

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Wang, Y.-K.; Han, J.; Xiong, W.-J.; Yuan, Q.-Y.; Gu, Y.-P.; Li, J.; Zhu, Z.; Zhang, H.; Wang, C.-J. Evaluation of in Vivo Antioxidant and Immunity Enhancing Activities of Sodium Aescinate Injection Liquid. Molecules 2012, 17, 10267-10275.

AMA Style

Wang Y-K, Han J, Xiong W-J, Yuan Q-Y, Gu Y-P, Li J, Zhu Z, Zhang H, Wang C-J. Evaluation of in Vivo Antioxidant and Immunity Enhancing Activities of Sodium Aescinate Injection Liquid. Molecules. 2012; 17(9):10267-10275.

Chicago/Turabian Style

Wang, Yong-Kun; Han, Jiang; Xiong, Wu-Jun; Yuan, Qiong-Ying; Gu, Yan-Ping; Li, Jun; Zhu, Zhe; Zhang, Hui; Wang, Cong-Jun. 2012. "Evaluation of in Vivo Antioxidant and Immunity Enhancing Activities of Sodium Aescinate Injection Liquid." Molecules 17, no. 9: 10267-10275.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert